ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,530.93
      1.56%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      05/04/20214:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      05/04/20214:01PMGlobeNewswire Inc.ESPERION Reports First Quarter 2021 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      04/28/20214:05PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      04/27/20218:00AMGlobeNewswire Inc.Esperion Announces Publication of Rationale and Design of Landmark CLEAR Cardiovascular Outcomes Trial Evaluating NEXLETOL® ...NASDAQ:ESPREsperion Therapeutics Inc
      04/26/20215:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      04/26/20214:07PMGlobeNewswire Inc.Esperion Secures $50 Million Funding from Oberland CapitalNASDAQ:ESPREsperion Therapeutics Inc
      04/26/20214:02PMGlobeNewswire Inc.Esperion Expands Partnership with Daiichi Sankyo Group to Additional TerritoriesNASDAQ:ESPREsperion Therapeutics Inc
      04/15/20214:03PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ESPREsperion Therapeutics Inc
      04/12/20214:01PMGlobeNewswire Inc.Esperion to Report First Quarter 2021 Financial Results May 4, 2021NASDAQ:ESPREsperion Therapeutics Inc
      04/06/20218:00AMGlobeNewswire Inc.Esperion to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      03/17/20214:05PMGlobeNewswire Inc.NEXLETOL® (bempedoic acid) Tablet, ezetimibe and atorvastatin combination lowered bad cholesterol by 60.5% vs. placebo in Ph...NASDAQ:ESPREsperion Therapeutics Inc
      02/23/20215:18PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ESPREsperion Therapeutics Inc
      02/23/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      02/23/20214:01PMGlobeNewswire Inc.ESPERION Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      02/16/20214:53PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/16/20219:57AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/12/20215:35PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/12/20216:04AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      02/11/20211:03PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      02/09/20212:57PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/09/20218:00AMGlobeNewswire Inc.Esperion to Report Fourth Quarter and Full Year 2020 Financial Results February 23, 2021NASDAQ:ESPREsperion Therapeutics Inc
      02/05/20217:55AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/03/20212:55AMTipRanksEsperion Therapeutics: The Good, Bad and UglyNASDAQ:ESPREsperion Therapeutics Inc
      01/29/20215:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      01/29/20215:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      01/29/20215:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      01/29/20215:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      01/29/20215:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      01/13/20217:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      01/13/20216:26AMGlobeNewswire Inc.ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9...NASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR

      Your Recent History

      BIT
      X45696
      Natixis Structured Issua...
      Delayed Upgrade Clock